261 related articles for article (PubMed ID: 18632868)
41. The Interferon-Stimulated Gene Ifi27l2a Restricts West Nile Virus Infection and Pathogenesis in a Cell-Type- and Region-Specific Manner.
Lucas TM; Richner JM; Diamond MS
J Virol; 2015 Dec; 90(5):2600-15. PubMed ID: 26699642
[TBL] [Abstract][Full Text] [Related]
42. Genetic diversity in the collaborative cross model recapitulates human West Nile virus disease outcomes.
Graham JB; Thomas S; Swarts J; McMillan AA; Ferris MT; Suthar MS; Treuting PM; Ireton R; Gale M; Lund JM
mBio; 2015 May; 6(3):e00493-15. PubMed ID: 25944860
[TBL] [Abstract][Full Text] [Related]
43. Death receptor-mediated apoptotic signaling is activated in the brain following infection with West Nile virus in the absence of a peripheral immune response.
Clarke P; Leser JS; Quick ED; Dionne KR; Beckham JD; Tyler KL
J Virol; 2014 Jan; 88(2):1080-9. PubMed ID: 24198425
[TBL] [Abstract][Full Text] [Related]
44. Potentiation of West Nile encephalitis by mosquito feeding.
Schneider BS; Soong L; Girard YA; Campbell G; Mason P; Higgs S
Viral Immunol; 2006; 19(1):74-82. PubMed ID: 16553552
[TBL] [Abstract][Full Text] [Related]
45. Inactivated West Nile Virus (WNV) vaccine, Duvaxyn WNV, protects against a highly neuroinvasive lineage 2 WNV strain in mice.
Venter M; van Vuren PJ; Mentoor J; Paweska J; Williams J
Vaccine; 2013 Aug; 31(37):3856-62. PubMed ID: 23820079
[TBL] [Abstract][Full Text] [Related]
46. Assessment of Immunoglobulin M Enzyme-Linked Immunosorbent Assay Ratios to Identify West Nile Virus and St. Louis Encephalitis Virus Infections During Concurrent Outbreaks of West Nile Virus and St. Louis Encephalitis Virus Diseases, Arizona 2015.
Curren EJ; Venkat H; Sunenshine R; Fitzpatrick K; Kosoy O; Krow-Lucal E; Zabel K; Adams L; Kretschmer M; Fischer M; Hills SL
Vector Borne Zoonotic Dis; 2020 Aug; 20(8):619-623. PubMed ID: 32315576
[TBL] [Abstract][Full Text] [Related]
47. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.
Desprès P; Combredet C; Frenkiel MP; Lorin C; Brahic M; Tangy F
J Infect Dis; 2005 Jan; 191(2):207-14. PubMed ID: 15609230
[TBL] [Abstract][Full Text] [Related]
48. Matrix-M™ adjuvanted envelope protein vaccine protects against lethal lineage 1 and 2 West Nile virus infection in mice.
Magnusson SE; Karlsson KH; Reimer JM; Corbach-Söhle S; Patel S; Richner JM; Nowotny N; Barzon L; Bengtsson KL; Ulbert S; Diamond MS; Stertman L
Vaccine; 2014 Feb; 32(7):800-8. PubMed ID: 24380682
[TBL] [Abstract][Full Text] [Related]
49. Influence of Biological Model on the Formation of the Pathogenic Properties of the West Nile Virus Isolate.
Molchanova EV; Negodenko AO; Luchinin DN; Prilepskaya DR; Khabarova IA; Boroday NV; Baturin AA; Andrianov BV
Bull Exp Biol Med; 2021 Aug; 171(4):513-516. PubMed ID: 34542764
[TBL] [Abstract][Full Text] [Related]
50. Pregnancy increases the risk of mortality in West Nile virus-infected mice.
Córdoba L; Escribano-Romero E; Garmendia A; Saiz JC
J Gen Virol; 2007 Feb; 88(Pt 2):476-480. PubMed ID: 17251565
[TBL] [Abstract][Full Text] [Related]
51. Differential Roles of Chemokines CCL2 and CCL7 in Monocytosis and Leukocyte Migration during West Nile Virus Infection.
Bardina SV; Michlmayr D; Hoffman KW; Obara CJ; Sum J; Charo IF; Lu W; Pletnev AG; Lim JK
J Immunol; 2015 Nov; 195(9):4306-18. PubMed ID: 26401006
[TBL] [Abstract][Full Text] [Related]
52. West Nile encephalitis outbreak in Kerala, India, 2011.
Anukumar B; Sapkal GN; Tandale BV; Balasubramanian R; Gangale D
J Clin Virol; 2014 Sep; 61(1):152-5. PubMed ID: 24985196
[TBL] [Abstract][Full Text] [Related]
53. Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier.
Lazear HM; Daniels BP; Pinto AK; Huang AC; Vick SC; Doyle SE; Gale M; Klein RS; Diamond MS
Sci Transl Med; 2015 Apr; 7(284):284ra59. PubMed ID: 25904743
[TBL] [Abstract][Full Text] [Related]
54. Antiviral peptides targeting the west nile virus envelope protein.
Bai F; Town T; Pradhan D; Cox J; Ashish ; Ledizet M; Anderson JF; Flavell RA; Krueger JK; Koski RA; Fikrig E
J Virol; 2007 Feb; 81(4):2047-55. PubMed ID: 17151121
[TBL] [Abstract][Full Text] [Related]
55. Experimental North American West Nile Virus Infection in the Red-legged Partridge (Alectoris rufa).
Gamino V; Escribano-Romero E; Blázquez AB; Gutiérrez-Guzmán AV; Martín-Acebes MÁ; Saiz JC; Höfle U
Vet Pathol; 2016 May; 53(3):585-93. PubMed ID: 26508695
[TBL] [Abstract][Full Text] [Related]
56. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice.
Liu WJ; Wang XJ; Clark DC; Lobigs M; Hall RA; Khromykh AA
J Virol; 2006 Mar; 80(5):2396-404. PubMed ID: 16474146
[TBL] [Abstract][Full Text] [Related]
57. Setting up a SPF chicken model for the pathotyping of West Nile virus (WNV) strains.
Dridi M; Rauw F; Muylkens B; Lecollinet S; van den Berg T; Lambrecht B
Transbound Emerg Dis; 2013 Nov; 60 Suppl 2():51-62. PubMed ID: 24589102
[TBL] [Abstract][Full Text] [Related]
58. Methods to Study West Nile Virus Infection and the Virus-Induced Inflammation in the Brain in a Murine Model.
Luo H; Wang T
Methods Mol Biol; 2023; 2585():41-49. PubMed ID: 36331764
[TBL] [Abstract][Full Text] [Related]
59. Lessons from the Murine Models of West Nile Virus Infection.
McGruder B; Saxena V; Wang T
Methods Mol Biol; 2016; 1435():61-9. PubMed ID: 27188550
[TBL] [Abstract][Full Text] [Related]
60. CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis.
Wang Y; Lobigs M; Lee E; Müllbacher A
J Virol; 2003 Dec; 77(24):13323-34. PubMed ID: 14645588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
